KYTX Kyverna Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
06:01
Nov 13
Nov 13
r/stocks
First-in-class SPS BLA done; expect takeover soon
Author argues Kyverna is first-in-class with no competition in stiff person syndrome after completing its BLA submission for miv-cel on November 12. Supporting points include potential beyond SPS, a Phase 3 gMG program, Gilead's ~6.8% stake and ex-KITE/Gilead leadership. The stated catalyst is an expected takeover offer within the next few months; the main risk implied is that the takeover may not materialize.
KYTX
Kyverna Therapeutics, Inc.
Long
1ST
—
—
About KYTX Investor Commentary
Across the available history and selected sources, Buzzberg tracks KYTX (Kyverna Therapeutics, Inc.) across 5 sources: 1 bullish vs 0 bearish calls from 5 authors. Historical directional balance: 20% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 5 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/UniverseWillDecide.